Tandem Diabetes Care: Q3 Earnings Insights

Tandem Diabetes Care TNDM reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:05 PM.

Here's what investors need to know about the announcement.

Tandem Diabetes Care their estimated earnings by 50.0%, reporting an EPS of $0.09 versus an estimate of $0.06, which surprised analysts.

Revenue was up $56,024,000 from the same period last year.

Last quarter the company beat on EPS by $0.14, which was followed by a 4.73% increase in the share price the next day.

Here's a look at Tandem Diabetes Care's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	-0.08	-0.16	0.12	-0.10
EPS Actual	0.06	-0.08	0.22	-0.15
Revenue Estimate	143.63M	121.96M	141.58M	115.15M
Revenue Actual	172.14M	141.04M	168.06M	123.60M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Earnings Calendar